楚江新材(002171.SZ):公司的精密銅帶和導體材料可應用於連接器、連接線束線纜等產品 相關產品已向安費諾供貨
格隆匯6月19日丨近日,有投資者通過投資者互動平台向楚江新材(002171.SZ)提問:董祕您好,據媒體報道:英偉達為建立超級算力數據中心,推出了最新DAC方案,DAC將替代光模塊+液冷,成本是光模塊的五分之一,是性價比最高的新技術。安費諾是全球最大的DAC廠家和服務連接器龍頭,產品佔全球市場份額的60%,是英偉達的主要供應商。請問:貴公司的銅基材料在上述領域有應用嗎?是否向安費諾供貨?
楚江新材(002171.SZ)6月19日在投資者互動平台表示,尊敬的投資者您好,公司的精密銅帶和導體材料可應用於連接器、連接線束線纜等產品,相關產品已向安費諾供貨,謝謝!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.